Titan Pharmaceuticals, Inc. common stock (TTNP) stock is lower by -44.65% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives TTNP stock a score of 10 out of a possible 100.
That rank is chiefly influenced by a fundamental score of 0. TTNP's rank also includes a short-term technical score of 11. The long-term technical score for TTNP is 19.
What's Happening with TTNP Stock Today
Titan Pharmaceuticals, Inc. common stock (TTNP) stock has fallen -1.12% while the S&P 500 is up 0.18% as of 11:41 AM on Tuesday, Dec 8. TTNP is lower by -$0.04 from the previous closing price of $3.56 on volume of 655,261 shares. Over the past year the S&P 500 is up 17.94% while TTNP is lower by -44.65%. TTNP lost -$7.39 per share in the over the last 12 months.